06/02/2025NCIRS webinarAustralian RSV immunisation update – new funded programs for infant protection NCIRS webinar series Main navigation Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series Upcoming – What’s new in pneumococcal vaccination for infants, children and adolescents 25/06/2025 – Navigating vaccination for immunocompromised patients: New Handbook guidance 27/03/2025 – Triple protection: Vaccines for influenza, COVID-19 and RSV in 2025 06/02/2025 – Australian RSV immunisation update – new funded programs for infant protection 10/10/2024 – Falling childhood vaccination rates: current context and future strategies 08/08/2024 – Rabies, travel vaccines and global trends in vaccine-preventable diseases 27/03/2024 – Influenza and COVID-19 vaccination update 07/03/2024 – RSV vaccines for the protection of older adults 27/02/2024 – New RSV vaccine and antibody to prevent disease in infants 07/11/2023 - New shingles vaccine on Australia's NIP 22/09/23 – Vaccination for people with disability 05/05/2023: HPV in 2023 – latest vaccine recommendations and research 16/03/2023: COVID-19 and influenza vaccination update 2023 8/11/2022: Mpox (formerly monkeypox) vaccines 01/09/2022: Emerging vaccine preventable diseases and vaccination for travel 12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines 05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022 03/03/2022: Living with COVID-19: Getting back to immunisation business as usual 8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes 13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW 26/08/21 - What’s next for Australia’s COVID-19 vaccine program? 24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific 30/04/2021: Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptake 31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when 17/3/2021: COVID-19 vaccine safety in focus 19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2 12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1 23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight? 22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings 16/6/2020 - National Immunisation Program changes: what you need to know 17/03/2020 - 2020 influenza program update 18/2/2020 - Measles a local, regional and global perspective 10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation 22/10/19 - Addressing parents’ immunisation communication and information needs and SKAI eLearning module & provider website launch 23/7/19 - HPV vaccination impact: successes and opportunities 4/6/19- Deadly diseases: a history and the current battle against measles 1/5/19 - Protecting our most vulnerable children from influenza: we can do better 20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy 18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help 21/11/18 - Australian Immunisation Register & Handbook Update 3/10/18 - Immunisation through an equity lens: New Zealand and global 19/09/18 Vaccine safety and adverse events following immunisation: a practical approach 11/07/18 - National Immunisation Program schedule changes - Your questions answered 31/05/18 Maternal vaccination: The knowns and unknowns 23/4/18 - Active surveillance for immunisation programs 12/03/18 - Influenza prevention and control: We can do better 22/11/17 - Tailoring Immunization Programmes (TIP) 27/09/17 - Addressing vaccine hesitancy and refusal 23/08/17 Varicella Zoster Virus Vaccines 26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine 24/05/17 Maternal Immunisation against Pertussis 22/03/17 - A One Health Approach to the Problem of Q Fever 22/2/17 - Pneumococcal vaccines for elderly adults UPCOMING - NCIRS Seminar Series - Tuesday 4 June - Deadly diseases: a history and the current battle against measles Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety NCIRS webinar series Main navigation Australian Immunisation Handbook COVID-19 vaccines Immunisation coverage data and reports Education and training History of immunisation Immunisation schedules National and international resources NCIRS fact sheets, FAQs and other resources NCIRS webinar series Upcoming – What’s new in pneumococcal vaccination for infants, children and adolescents 25/06/2025 – Navigating vaccination for immunocompromised patients: New Handbook guidance 27/03/2025 – Triple protection: Vaccines for influenza, COVID-19 and RSV in 2025 06/02/2025 – Australian RSV immunisation update – new funded programs for infant protection 10/10/2024 – Falling childhood vaccination rates: current context and future strategies 08/08/2024 – Rabies, travel vaccines and global trends in vaccine-preventable diseases 27/03/2024 – Influenza and COVID-19 vaccination update 07/03/2024 – RSV vaccines for the protection of older adults 27/02/2024 – New RSV vaccine and antibody to prevent disease in infants 07/11/2023 - New shingles vaccine on Australia's NIP 22/09/23 – Vaccination for people with disability 05/05/2023: HPV in 2023 – latest vaccine recommendations and research 16/03/2023: COVID-19 and influenza vaccination update 2023 8/11/2022: Mpox (formerly monkeypox) vaccines 01/09/2022: Emerging vaccine preventable diseases and vaccination for travel 12/05/2022: Preventing shingles (herpes zoster) and its complications using zoster vaccines - and a quick update on COVID-19 vaccines 05/04/2022: Managing seasonal respiratory viruses: Flu and SARS-CoV-2 Winter 2022 03/03/2022: Living with COVID-19: Getting back to immunisation business as usual 8/12/2021: COVID-19 in children and adolescents: vaccines, transmission at school and disease outcomes 13/10/2021: Weighing up the benefits and risks of COVID-19 vaccination: a focus on safety - REGISTER NOW 26/08/21 - What’s next for Australia’s COVID-19 vaccine program? 24/06/2021 - Supporting COVID-19 vaccine access in the Indo-Pacific 30/04/2021: Australia’s COVID-19 vaccine program reset: navigating safety, acceptance and uptake 31/03/21: COVID-19 and 2021 influenza vaccines – the how, what, why and when 17/3/2021: COVID-19 vaccine safety in focus 19/2/2021: Out of the starting blocks: COVID-19 vaccination program in Australia - Part 2 12/02/2021 - Out of the starting blocks: COVID-19 vaccination program in Australia - Part 1 23/11/2020 - SARS-CoV-2 vaccine development: is a finish line in sight? 22/09/2020: Learning together – Transmission of SARS-CoV-2 in NSW educational settings 16/6/2020 - National Immunisation Program changes: what you need to know 17/03/2020 - 2020 influenza program update 18/2/2020 - Measles a local, regional and global perspective 10/12/19 - Working together to improve Aboriginal and Torres Strait Islander immunisation 22/10/19 - Addressing parents’ immunisation communication and information needs and SKAI eLearning module & provider website launch 23/7/19 - HPV vaccination impact: successes and opportunities 4/6/19- Deadly diseases: a history and the current battle against measles 1/5/19 - Protecting our most vulnerable children from influenza: we can do better 20/3/19 - All you need to know about Flu in 2019 plus great new tool to support vaccination in pregnancy 18/2/2019 - Conversations with vaccine-hesitant parents: how the new SKAI website can help 21/11/18 - Australian Immunisation Register & Handbook Update 3/10/18 - Immunisation through an equity lens: New Zealand and global 19/09/18 Vaccine safety and adverse events following immunisation: a practical approach 11/07/18 - National Immunisation Program schedule changes - Your questions answered 31/05/18 Maternal vaccination: The knowns and unknowns 23/4/18 - Active surveillance for immunisation programs 12/03/18 - Influenza prevention and control: We can do better 22/11/17 - Tailoring Immunization Programmes (TIP) 27/09/17 - Addressing vaccine hesitancy and refusal 23/08/17 Varicella Zoster Virus Vaccines 26/07/17 - Tuberculosis & the Bacille Calmette-Guérin (BCG) vaccine 24/05/17 Maternal Immunisation against Pertussis 22/03/17 - A One Health Approach to the Problem of Q Fever 22/2/17 - Pneumococcal vaccines for elderly adults UPCOMING - NCIRS Seminar Series - Tuesday 4 June - Deadly diseases: a history and the current battle against measles Patient communication resources Specialist immunisation services SKAI - supporting health professionals NCIRS newsletters Vaccine safety Watch our webinar on how infants across Australia will benefit from new respiratory syncytial virus (RSV) protection programs (introduced 3 February 2025), which includes a nationally-funded vaccination program for pregnant women, and state- and territory-funded long-acting monoclonal antibody programs for infants. Our panel of leading experts presented on:RSV disease in infants and young children effectiveness and safety of RSV vaccination and long-acting monoclonal antibody the new NIP-funded RSV vaccination program for pregnant women to protect their infantscomplementary state- and territory-funded RSV long-acting monoclonal antibody programsRSV prevention program resources to support healthcare providers.View the Q&A panel discussion below.Access NCIRS' RSV resourcesPresenters and recordings Professor Kristine Macartney – Director, NCIRS Welcome and opening remarks Kristine Macartney is a paediatrician and infectious disease specialist. She is a medical graduate of the University of NSW and has over 20 years of experience in vaccinology.She has experience working in the US at the Children’s Hospital of Philadelphia, where she was a founding member of the US Vaccine Education Center. Her Doctorate of Medicine was on rotavirus infection, in particular the mucosal immune response to novel vaccine candidates. She is interested in all aspects of vaccine preventable disease research, particularly policy development, vaccine safety and prevention of viral diseases. She is the Senior Editor of the Australian Immunisation Handbook. Kristine is a Staff Specialist in Infectious Diseases and Microbiology at the Children’s Hospital at Westmead and has a conjoint academic appointment as Professor in the Discipline of Child and Adolescent Health at the University of Sydney. Dr Archana Koirala – Senior Medical Officer, NCIRS RSV disease and Beyfortus Archana Koirala is a paediatric infectious disease specialist who joined NCIRS in 2018. She is part of the New South Wales Immunisation Specialist Service (NSWISS) team and reviews children who have experienced an adverse event following immunisation. She also works at Nepean Hospital and is a Clinical Lecturer at the University of Sydney. Professor Michelle Giles – Lead Clinical and Health Systems Research, the Doherty Institute Abrysvo and vaccination in pregnancy Michelle Giles is a lead of the Clinical and Health Systems Research cross-cutting discipline at the Doherty Institute. She is an infectious diseases physician and clinician scientist specialising in infections in pregnancy and maternal immunisation. Michelle supported the Australian Government’s response during the COVID-19 pandemic, focusing on control of community transmission of infection and in leading policy advice for the COVID-19 vaccination program.Michelle holds clinical appointments at Alfred Health, The Royal Women’s Hospital, Monash Health and Western Health, and has academic appointments at the Department of Infectious Diseases, University of Melbourne and the Department of Obstetrics and Gynaecology, Monash University. Dr Helen Chu – Professor of Medicine, University of Washington and Infectious Diseases Specialist US RSV prevention programs Helen is a member of the U.S. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices. Her research is focused on emerging respiratory viral infections and maternal-fetal immunity against respiratory viruses.Helen earned her MD from Duke University, USA. She completed her internal medicine residency at Harvard-Beth Israel Deaconess Medical Center, and her fellowship and MPH at University of Washington. Dr Anna Peatt – First Assistant Secretary, National Immunisation, Australian Government National RSV Maternal and Infant Protection Program (RSV MIPP) Anna Peatt leads the division responsible for the National Immunisation Program and the National COVID-19 Vaccine Program. These programs work to prevent disease and death through access to vaccines and the provision of better supports to the delivery of outcomes across the Department, as teams share their expertise, knowledge and capacity. Anna’s previous roles have included First Assistant Secretary, National COVID-19 Vaccine Division and Deputy Chief Executive Officer at the National Blood Authority. She previously worked at the Victorian Department of Health and Human Services, as the Chief Officer, Medicines and Poisons Regulation. Anna has more than 20 years’ experience in various roles throughout the Australian Government working in various departments, mainly in high-level positions. Her knowledge is enhanced by a Doctor of Philosophy (Chemistry), which she attained at Monash University. Adjunct Professor (Practice) Alison McMillan – Chief Nursing and Midwifery, Australian Government Department of Health and Aged Care National RSV Maternal and Infant Protection Program (RSV MIPP) As the Australian Government’s Chief Nursing and Midwifery Officer, Alison McMillan provides high-level strategic policy advice on nursing, midwifery, health system reform, health workforce, regulation and education to the Minister for Health and Aged Care, Minister for Aged Care and Minister for Sport, Assistant Minister for Health and Aged Care, Assistant Minister for Mental Health and Suicide Prevention, Assistant Minister Rural and Regional Health, Assistant Minister for Indigenous Health, and the Executive and staff within the Department of Health and Aged Care and other Government departments. Alison is an Adjunct Professor (Practice) at Monash University and a Distinguished Alumni of Latrobe University. She has received several awards, including a Public Service Medal for outstanding public service to driving the Government's national health response priorities during the COVID-19 pandemic – particularly to infection prevention measures – in June 2021, a National Emergency Medal in recognition of service following the 2009 Victorian Bushfires and a Humanitarian Overseas Medal in 2021. Dr Sonya Ennis – Jurisdiction Immunisation Committee (JIC) representative, Australian Technical Advisory Group on Immunisation (ATAGI), Associate Director Immunisation, NSW Health Practical tips for administering Abrysvo and Beyfortus Sonya Ennis joined the National Meningococcal C Vaccination Program in 2003 and was a Senior Policy Analyst in the Immunisation Unit for 15 years before taking on the Associate Director’s role in 2018. Before joining the Immunisation Unit, Sonya was a Registered Nurse in ICU for many years. Sonya completed a Master of Public Health in 2008 and a Professional Doctorate of Public Health in 2018, where her research interests were measles and pertussis control in vulnerable populations. Q&A panel – Dr Emma Goeman – Senior Medical Officer, NCIRS Emma Goeman joined NCIRS as a Staff Specialist in 2021. She is a clinical microbiologist for Australian Clinical Labs and a Clinical Senior Lecturer at the University of Sydney. Emma has experience working as an infectious diseases physician and clinical microbiologist at a large public tertiary hospital in Sydney.Emma graduated from the University of Melbourne in 2005, and trained in paediatrics, infectious diseases and clinical microbiology in Melbourne, Alice Springs and Sydney. She obtained Fellowships of the RACP (Infectious Diseases, Paediatrics and Child Health Division) and RCPA (Microbiology) in 2017. Full webinar recording News & events News | 11 September 2025 There’s a new vaccine for pneumococcal disease in Australia. Here’s what to know News | 10 September 2025 Measles in Vietnam: breaking the cycle for good News | 05 September 2025 Australian Vaccinology Course launches with impact News | 28 August 2025 NCIRS Global Health: accelerating immunisation progress across Southeast Asia and the Pacific 9535 views